This report aims to provide a comprehensive presentation of the global market for Tinea Corporis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tinea Corporis Treatment. This report contains market size and forecasts of Tinea Corporis Treatment in global, including the following market information:
Global Tinea Corporis Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Tinea Corporis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Topical Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Tinea Corporis Treatment include Perrigo Company, Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., Breckenridge Pharmaceutical, Inc., NorthStar Rx LLC, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc. and AvKare, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tinea Corporis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tinea Corporis Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Tinea Corporis Treatment Market Segment Percentages, by Type, 2022 (%)
Topical
Oral
Global Tinea Corporis Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Tinea Corporis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Others
Global Tinea Corporis Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Tinea Corporis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tinea Corporis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tinea Corporis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Perrigo Company
Taro Pharmaceuticals U.S.A., Inc.
Teva Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Inc.
Breckenridge Pharmaceutical, Inc.
NorthStar Rx LLC
Aurobindo Pharma Limited
Camber Pharmaceuticals, Inc.
AvKare, Inc.
Novartis AG
Sebela Pharmaceuticals, Inc.
Bayer AG
Blueberry Therapeutics Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tinea Corporis Treatment, market overview.
Chapter 2: Global Tinea Corporis Treatment market size in revenue.
Chapter 3: Detailed analysis of Tinea Corporis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tinea Corporis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tinea Corporis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tinea Corporis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tinea Corporis Treatment Overall Market Size
2.1 Global Tinea Corporis Treatment Market Size: 2022 VS 2030
2.2 Global Tinea Corporis Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tinea Corporis Treatment Players in Global Market
3.2 Top Global Tinea Corporis Treatment Companies Ranked by Revenue
3.3 Global Tinea Corporis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tinea Corporis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tinea Corporis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tinea Corporis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Tinea Corporis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Tinea Corporis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tinea Corporis Treatment Market Size Markets, 2022 & 2030
4.1.2 Topical
4.1.3 Oral
4.2 By Type - Global Tinea Corporis Treatment Revenue & Forecasts
4.2.1 By Type - Global Tinea Corporis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Tinea Corporis Treatment Revenue, 2024-2030
4.2.3 By Type - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tinea Corporis Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Tinea Corporis Treatment Revenue & Forecasts
5.2.1 By Application - Global Tinea Corporis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Tinea Corporis Treatment Revenue, 2024-2030
5.2.3 By Application - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tinea Corporis Treatment Market Size, 2022 & 2030
6.2 By Region - Global Tinea Corporis Treatment Revenue & Forecasts
6.2.1 By Region - Global Tinea Corporis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Tinea Corporis Treatment Revenue, 2024-2030
6.2.3 By Region - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tinea Corporis Treatment Revenue, 2018-2030
6.3.2 US Tinea Corporis Treatment Market Size, 2018-2030
6.3.3 Canada Tinea Corporis Treatment Market Size, 2018-2030
6.3.4 Mexico Tinea Corporis Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tinea Corporis Treatment Revenue, 2018-2030
6.4.2 Germany Tinea Corporis Treatment Market Size, 2018-2030
6.4.3 France Tinea Corporis Treatment Market Size, 2018-2030
6.4.4 U.K. Tinea Corporis Treatment Market Size, 2018-2030
6.4.5 Italy Tinea Corporis Treatment Market Size, 2018-2030
6.4.6 Russia Tinea Corporis Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Tinea Corporis Treatment Market Size, 2018-2030
6.4.8 Benelux Tinea Corporis Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tinea Corporis Treatment Revenue, 2018-2030
6.5.2 China Tinea Corporis Treatment Market Size, 2018-2030
6.5.3 Japan Tinea Corporis Treatment Market Size, 2018-2030
6.5.4 South Korea Tinea Corporis Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Tinea Corporis Treatment Market Size, 2018-2030
6.5.6 India Tinea Corporis Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tinea Corporis Treatment Revenue, 2018-2030
6.6.2 Brazil Tinea Corporis Treatment Market Size, 2018-2030
6.6.3 Argentina Tinea Corporis Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tinea Corporis Treatment Revenue, 2018-2030
6.7.2 Turkey Tinea Corporis Treatment Market Size, 2018-2030
6.7.3 Israel Tinea Corporis Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Tinea Corporis Treatment Market Size, 2018-2030
6.7.5 UAE Tinea Corporis Treatment Market Size, 2018-2030
7 Tinea Corporis Treatment Companies Profiles
7.1 Perrigo Company
7.1.1 Perrigo Company Company Summary
7.1.2 Perrigo Company Business Overview
7.1.3 Perrigo Company Tinea Corporis Treatment Major Product Offerings
7.1.4 Perrigo Company Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.1.5 Perrigo Company Key News & Latest Developments
7.2 Taro Pharmaceuticals U.S.A., Inc.
7.2.1 Taro Pharmaceuticals U.S.A., Inc. Company Summary
7.2.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview
7.2.3 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Major Product Offerings
7.2.4 Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.2.5 Taro Pharmaceuticals U.S.A., Inc. Key News & Latest Developments
7.3 Teva Pharmaceuticals, Inc.
7.3.1 Teva Pharmaceuticals, Inc. Company Summary
7.3.2 Teva Pharmaceuticals, Inc. Business Overview
7.3.3 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Major Product Offerings
7.3.4 Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Glenmark Pharmaceuticals Inc.
7.4.1 Glenmark Pharmaceuticals Inc. Company Summary
7.4.2 Glenmark Pharmaceuticals Inc. Business Overview
7.4.3 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Major Product Offerings
7.4.4 Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.4.5 Glenmark Pharmaceuticals Inc. Key News & Latest Developments
7.5 Breckenridge Pharmaceutical, Inc.
7.5.1 Breckenridge Pharmaceutical, Inc. Company Summary
7.5.2 Breckenridge Pharmaceutical, Inc. Business Overview
7.5.3 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Major Product Offerings
7.5.4 Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.5.5 Breckenridge Pharmaceutical, Inc. Key News & Latest Developments
7.6 NorthStar Rx LLC
7.6.1 NorthStar Rx LLC Company Summary
7.6.2 NorthStar Rx LLC Business Overview
7.6.3 NorthStar Rx LLC Tinea Corporis Treatment Major Product Offerings
7.6.4 NorthStar Rx LLC Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.6.5 NorthStar Rx LLC Key News & Latest Developments
7.7 Aurobindo Pharma Limited
7.7.1 Aurobindo Pharma Limited Company Summary
7.7.2 Aurobindo Pharma Limited Business Overview
7.7.3 Aurobindo Pharma Limited Tinea Corporis Treatment Major Product Offerings
7.7.4 Aurobindo Pharma Limited Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.7.5 Aurobindo Pharma Limited Key News & Latest Developments
7.8 Camber Pharmaceuticals, Inc.
7.8.1 Camber Pharmaceuticals, Inc. Company Summary
7.8.2 Camber Pharmaceuticals, Inc. Business Overview
7.8.3 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Major Product Offerings
7.8.4 Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.8.5 Camber Pharmaceuticals, Inc. Key News & Latest Developments
7.9 AvKare, Inc.
7.9.1 AvKare, Inc. Company Summary
7.9.2 AvKare, Inc. Business Overview
7.9.3 AvKare, Inc. Tinea Corporis Treatment Major Product Offerings
7.9.4 AvKare, Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.9.5 AvKare, Inc. Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Tinea Corporis Treatment Major Product Offerings
7.10.4 Novartis AG Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.10.5 Novartis AG Key News & Latest Developments
7.11 Sebela Pharmaceuticals, Inc.
7.11.1 Sebela Pharmaceuticals, Inc. Company Summary
7.11.2 Sebela Pharmaceuticals, Inc. Business Overview
7.11.3 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Major Product Offerings
7.11.4 Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.11.5 Sebela Pharmaceuticals, Inc. Key News & Latest Developments
7.12 Bayer AG
7.12.1 Bayer AG Company Summary
7.12.2 Bayer AG Business Overview
7.12.3 Bayer AG Tinea Corporis Treatment Major Product Offerings
7.12.4 Bayer AG Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.12.5 Bayer AG Key News & Latest Developments
7.13 Blueberry Therapeutics Ltd
7.13.1 Blueberry Therapeutics Ltd Company Summary
7.13.2 Blueberry Therapeutics Ltd Business Overview
7.13.3 Blueberry Therapeutics Ltd Tinea Corporis Treatment Major Product Offerings
7.13.4 Blueberry Therapeutics Ltd Tinea Corporis Treatment Revenue in Global Market (2018-2023)
7.13.5 Blueberry Therapeutics Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tinea Corporis Treatment Market Opportunities & Trends in Global Market
Table 2. Tinea Corporis Treatment Market Drivers in Global Market
Table 3. Tinea Corporis Treatment Market Restraints in Global Market
Table 4. Key Players of Tinea Corporis Treatment in Global Market
Table 5. Top Tinea Corporis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tinea Corporis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tinea Corporis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tinea Corporis Treatment Product Type
Table 9. List of Global Tier 1 Tinea Corporis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tinea Corporis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tinea Corporis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Tinea Corporis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tinea Corporis Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Tinea Corporis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Tinea Corporis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tinea Corporis Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Tinea Corporis Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Tinea Corporis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tinea Corporis Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tinea Corporis Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tinea Corporis Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tinea Corporis Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tinea Corporis Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tinea Corporis Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Perrigo Company Company Summary
Table 31. Perrigo Company Tinea Corporis Treatment Product Offerings
Table 32. Perrigo Company Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Perrigo Company Key News & Latest Developments
Table 34. Taro Pharmaceuticals U.S.A., Inc. Company Summary
Table 35. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Product Offerings
Table 36. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Taro Pharmaceuticals U.S.A., Inc. Key News & Latest Developments
Table 38. Teva Pharmaceuticals, Inc. Company Summary
Table 39. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offerings
Table 40. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceuticals, Inc. Key News & Latest Developments
Table 42. Glenmark Pharmaceuticals Inc. Company Summary
Table 43. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Product Offerings
Table 44. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Glenmark Pharmaceuticals Inc. Key News & Latest Developments
Table 46. Breckenridge Pharmaceutical, Inc. Company Summary
Table 47. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Product Offerings
Table 48. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Breckenridge Pharmaceutical, Inc. Key News & Latest Developments
Table 50. NorthStar Rx LLC Company Summary
Table 51. NorthStar Rx LLC Tinea Corporis Treatment Product Offerings
Table 52. NorthStar Rx LLC Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. NorthStar Rx LLC Key News & Latest Developments
Table 54. Aurobindo Pharma Limited Company Summary
Table 55. Aurobindo Pharma Limited Tinea Corporis Treatment Product Offerings
Table 56. Aurobindo Pharma Limited Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Aurobindo Pharma Limited Key News & Latest Developments
Table 58. Camber Pharmaceuticals, Inc. Company Summary
Table 59. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offerings
Table 60. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Camber Pharmaceuticals, Inc. Key News & Latest Developments
Table 62. AvKare, Inc. Company Summary
Table 63. AvKare, Inc. Tinea Corporis Treatment Product Offerings
Table 64. AvKare, Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. AvKare, Inc. Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Tinea Corporis Treatment Product Offerings
Table 68. Novartis AG Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis AG Key News & Latest Developments
Table 70. Sebela Pharmaceuticals, Inc. Company Summary
Table 71. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Product Offerings
Table 72. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Sebela Pharmaceuticals, Inc. Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Tinea Corporis Treatment Product Offerings
Table 76. Bayer AG Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Bayer AG Key News & Latest Developments
Table 78. Blueberry Therapeutics Ltd Company Summary
Table 79. Blueberry Therapeutics Ltd Tinea Corporis Treatment Product Offerings
Table 80. Blueberry Therapeutics Ltd Tinea Corporis Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Blueberry Therapeutics Ltd Key News & Latest Developments
List of Figures
Figure 1. Tinea Corporis Treatment Segment by Type in 2022
Figure 2. Tinea Corporis Treatment Segment by Application in 2022
Figure 3. Global Tinea Corporis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tinea Corporis Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Tinea Corporis Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tinea Corporis Treatment Revenue in 2022
Figure 8. By Type - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Tinea Corporis Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Tinea Corporis Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 16. US Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 28. China Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Tinea Corporis Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Tinea Corporis Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Perrigo Company Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Taro Pharmaceuticals U.S.A., Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Glenmark Pharmaceuticals Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Breckenridge Pharmaceutical, Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. NorthStar Rx LLC Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aurobindo Pharma Limited Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Camber Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AvKare, Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis AG Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sebela Pharmaceuticals, Inc. Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bayer AG Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Blueberry Therapeutics Ltd Tinea Corporis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
